Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Osteosarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00617890
What this trial is testing

Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720)

Who this might be right for
OsteosarcomaSarcoma, Ewing'sPeripheral Neuroectodermal Tumor
Merck Sharp & Dohme LLC 219
Testing effectiveness (Phase 2)Ended earlyNCT00788125
What this trial is testing

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
City of Hope Medical Center 7
Not applicableStudy completedNCT04651179
What this trial is testing

Study of Effectiveness of GEMDOX in Relapsed Osteosarcoma

Who this might be right for
Osteosarcoma RecurrentOsteosarcoma Metastatic
Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna 33
Testing effectiveness (Phase 2)Looking for participantsNCT04616560
What this trial is testing

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

Who this might be right for
Desmoplastic Small Round Cell TumorOsteosarcomaRecurrent Desmoplastic Small Round Cell Tumor+5 more
National Cancer Institute (NCI) 55
Not applicableStudy completedNCT00954473
What this trial is testing

Study of Blood Samples From Patients With Osteosarcoma

Who this might be right for
Localized OsteosarcomaMetastatic OsteosarcomaRecurrent Osteosarcoma
Children's Oncology Group 1,000
Early research (Phase 1)Study completedNCT00020267
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Lung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT04974008
What this trial is testing

Osteosarcoma Maintenance Therapy With OST31-164

Who this might be right for
Bone Cancer
Emerald Clinical Inc. 39
Not applicableLooking for participantsNCT07636148
What this trial is testing

Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance

Who this might be right for
Liver Cancer (Primary and Metastatic)Lung Cancer (Diagnosis)Bone Cancer Metastatic+10 more
Mark C Burgmans, MD PhD 2,000
Testing effectiveness (Phase 2)Study completedNCT01833520
What this trial is testing

Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma

Who this might be right for
Sarcoma
M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07444918
What this trial is testing

Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors

Who this might be right for
Relapsed or Refractory Pediatric Malignant Solid Tumors (Including Neuroblastoma, Rhabdomyosarcoma, Ewing Sarcoma, Osteosarcoma)
Tianjin Medical University Cancer Institute and Hospital 33
Early research (Phase 1)Study completedNCT02085148
What this trial is testing

A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard Therapy

Who this might be right for
Pediatric Oncology
Bayer 62
Testing effectiveness (Phase 2)Study completedNCT01154816
What this trial is testing

Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia

Who this might be right for
HepatoblastomaPreviously Treated Childhood RhabdomyosarcomaRecurrent Childhood Acute Lymphoblastic Leukemia+8 more
Children's Oncology Group 118
Early research (Phase 1)Study completedNCT00620295
What this trial is testing

Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+6 more
Masonic Cancer Center, University of Minnesota 17
Testing effectiveness (Phase 2)Study completedNCT03213665
What this trial is testing

Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Hodgkin LymphomaAnn Arbor Stage III Non-Hodgkin Lymphoma+38 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)UnknownNCT02173093
What this trial is testing

Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma

Who this might be right for
Disseminated NeuroblastomaRecurrent Neuroblastoma
University of Virginia 40
Not applicableStudy completedNCT01807052
What this trial is testing

Biomarker Expression in Tissue Samples From Patients With Bone Sarcomas

Who this might be right for
Localized OsteosarcomaMetastatic OsteosarcomaRecurrent Osteosarcoma
Children's Oncology Group 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT02243605
What this trial is testing

Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma

Who this might be right for
Metastatic Ewing SarcomaMetastatic OsteosarcomaRecurrent Ewing Sarcoma+7 more
National Cancer Institute (NCI) 90
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Early research (Phase 1)Looking for participantsNCT05400603
What this trial is testing

Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma

Who this might be right for
NeuroblastomaRefractory NeuroblastomaRelapsed Neuroblastoma+2 more
Emory University 24
Early research (Phase 1)Study completedNCT00036959
What this trial is testing

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
National Institutes of Health Clinical Center (CC) 90
Next Page